
Ian M. Gralnek, MD, MSHS
Advertisement
Articles by Ian M. Gralnek, MD, MSHS

Advertisement
Latest Updated Articles
- Budget Impact of Tegaserod on a Managed Care Organization Formulary
Published: April 15th 2005 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5